| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/09/1994 | CN1023938C Process for preparing naphthyl oxazolididone derivatives |
| 03/08/1994 | US5292887 Substituted imidazole derivatives and their preparation and use |
| 03/08/1994 | US5292769 Substituted mandelic acid derivatives and their use in medicaments |
| 03/08/1994 | US5292756 Novel sulfonamide fibrinogen receptor antagonists |
| 03/08/1994 | CA1327674C Method and apparatus for separating proteins |
| 03/08/1994 | CA1327570C Triazolo-thieno- and benzodiazepine derivatives as platelet activating factor antagonists |
| 03/05/1994 | CA2105213A1 Test for lupus anticoagulant |
| 03/03/1994 | WO1994004704A1 Effects of actin filaments on fibrin clot structure and lysis |
| 03/03/1994 | WO1994004531A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 03/03/1994 | WO1994004513A1 Pharmaceutically active diketopiperazines |
| 03/03/1994 | WO1994004512A1 Pharmaceutically active diketopiperazines |
| 03/03/1994 | WO1994004500A1 Cyanoguanidines as potassium channel blockers |
| 03/03/1994 | WO1994004499A1 Cyanoguanidines as potassium channel blockers |
| 03/03/1994 | WO1994004168A1 Anti-cancer therapeutic compositions containing whey protein concentrate |
| 03/03/1994 | WO1994004163A1 Novel glucan preparation |
| 03/03/1994 | DE4228926A1 Spritzfertige Azosemid-Injektionslösungen Spray Ready azosemide injection solutions |
| 03/03/1994 | CA2141939A1 Pharmaceutically active diketopiperazines |
| 03/03/1994 | CA2141938A1 Pharmaceutically active diketopiperazines |
| 03/02/1994 | EP0584845A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
| 03/02/1994 | EP0584694A1 Imidazolidin derivatives |
| 03/02/1994 | EP0584347A1 Enantiomeric hydroxylated xanthine compounds |
| 03/02/1994 | EP0584244A1 Peptide inhibitors of inflammation |
| 03/02/1994 | EP0584208A1 Pyrrolidinones |
| 03/02/1994 | EP0584066A1 Anti-thrombotic peptide and pseudopeptide derivatives |
| 03/02/1994 | EP0458929B1 SOLUBILIZATION OF t-PA |
| 03/02/1994 | EP0266419B1 Fibrinolytic composition |
| 03/02/1994 | CN1083075A Linear peptides |
| 03/02/1994 | CN1023901C Novel family of primate hematopoietic growth factors |
| 03/02/1994 | CN1023899C Production method of nutrition liquid |
| 03/01/1994 | US5290951 Intermediates useful in preparing propenone oxime ethers |
| 03/01/1994 | US5290799 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| 03/01/1994 | US5290788 Antiallergens for mammals |
| 03/01/1994 | US5290692 Calcium titanium phosphate glass with sodium oxide and fibrinolytic enzymes for conversion of plasminogen to plasmin bonded to the glass |
| 03/01/1994 | CA2101599A1 Tri- and tetracyclic compounds |
| 03/01/1994 | CA1327359C Prostaglandin el derivatives as pharmacologically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration |
| 03/01/1994 | CA1327334C Stimulation of stem cell growth by the bryostatins |
| 03/01/1994 | CA1327318C Pharmaceutical composition for the prevention and treatment of bacterial or viral diseases |
| 02/26/1994 | CA2104816A1 2-deoxy-2-amino hexuronyl derivatives of heparin and a method for production |
| 02/23/1994 | EP0583884A1 Megakaryocyte differentiation factor |
| 02/23/1994 | EP0583821A1 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction) |
| 02/23/1994 | EP0583699A1 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments |
| 02/23/1994 | EP0583698A2 Deoxycyclitol derivatives, process for their preparation and their use in medicaments |
| 02/23/1994 | EP0583322A1 Antiserotonines, prepartion thereof and medicaments containing them |
| 02/23/1994 | EP0477274B1 FACTOR Xa BASED ANTICOAGULANT COMPOSITIONS |
| 02/23/1994 | CN1082426A Traditional Chinese medicine preparation for curing microcircalatory disturbance and its preparing method |
| 02/22/1994 | US5288726 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation |
| 02/22/1994 | US5288629 Anticoagulants |
| 02/22/1994 | US5288607 Polypeptides having a β-adrenergic receptor activity in man, implicated in the lipolytic response, nucleic acids coding for these polypeptides and the use of these polypeptides for the screening of a substance active on these polypeptides |
| 02/19/1994 | CA2104051A1 Deoxymyoinositol derivatives, process for their preparation and their use in medicaments |
| 02/19/1994 | CA2104049A1 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments |
| 02/17/1994 | WO1994003614A1 Inhibitor resistant serine proteases |
| 02/17/1994 | WO1994003603A1 Novel glycoforms of soluble complement receptor 1 |
| 02/17/1994 | WO1994003488A1 Novel peptide |
| 02/17/1994 | WO1994003479A1 Thrombin receptor antagonists |
| 02/17/1994 | WO1994003442A1 3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof, a pharmaceutical preparation containing said compounds and the use of said compounds for the preparation of medicaments |
| 02/17/1994 | WO1994003165A1 Antithrombotic treatment with calix(n)arene compounds |
| 02/17/1994 | CA2140641A1 3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof, a pharmaceutical preparation containing said compounds and the use of said compounds for the preparation of medicaments |
| 02/16/1994 | EP0583136A2 Piperidino-3,4-dihydrocarbostyryl compounds for the treatment of ischemic disorders |
| 02/16/1994 | EP0582916A1 N-methansulfonyl-2-(3-isobutyl-3-(quinol-2-yl-methoxy)-phenyl)-2-cycloalkylacetamides, process for their preparation and their pharmaceutical use |
| 02/16/1994 | EP0582908A1 2-Substituted guinolylmethoxy-phenylacetic acid derivatives, process for their preparation and their pharmaceutical use |
| 02/16/1994 | EP0508995B1 Muscarinic receptor antagonists |
| 02/16/1994 | EP0343241B1 A method of inhibiting platelet dependent arterial thrombosis |
| 02/16/1994 | CN1082043A Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds |
| 02/16/1994 | CN1081909A Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 02/15/1994 | US5286858 Optically active thienotriazolodiazepine compounds |
| 02/15/1994 | US5286849 Purification of factor IX |
| 02/15/1994 | US5286714 Synthetic isohirudins with improved stability |
| 02/13/1994 | CA2103600A1 Isobutyl-substituted methanesulphonyl- quinolyl-methoxyphenyl-cycloalkylacetamides |
| 02/12/1994 | CA2103521A1 Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives |
| 02/12/1994 | CA2101998A1 Piperidino-3,4-dihydrocarbostyril compounds |
| 02/09/1994 | EP0581979A1 Quinic acid derivatives and process to prepare quinic acid derivatives |
| 02/09/1994 | EP0581967A1 Protein with novel pharmacological characteristic |
| 02/09/1994 | EP0581883A1 Blood substitutes and organ preservative solutions |
| 02/09/1994 | EP0581846A1 Sulfate polysaccharides, preparation method, pharmaceutical composition and utilization |
| 02/09/1994 | EP0497756B1 Antithrombotic composition |
| 02/09/1994 | CN1081715A Stem cell proliferation factor |
| 02/09/1994 | CN1023700C Aromatic and heterocyclic carboxamide derivatives as antineoplastic agent and preparation method thereof |
| 02/08/1994 | US5284755 DNA encoding leukemia inhibitory factor receptors |
| 02/08/1994 | US5284751 Detecting thrombi, clotting disorders |
| 02/08/1994 | CA1326851C Oxadiazolyl-1,4-dihydropyridines and the analogues thereof |
| 02/04/1994 | CA2101230A1 Derivatives of quinic acid and a process for their production |
| 02/03/1994 | WO1994002465A1 INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF |
| 02/03/1994 | WO1994002459A1 Indolinyl n-hydrozyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors |
| 02/03/1994 | WO1994002448A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 02/03/1994 | WO1994002447A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002446A1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002128A1 USE OF α,w DICARBOXYLIC ACIDS AS FIBRINOGEN REDUCERS |
| 02/03/1994 | CA2141214A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 02/03/1994 | CA2138128A1 Use of .alpha.-w-dicarboxylic acids as fibrinogen sinkers |
| 02/02/1994 | EP0581187A1 Oxime derivatives |
| 02/02/1994 | EP0580916A1 N(1) substituted pyrazino 2,3-c -1,2,6-thiadiazine 2,2-dioxides and their use as pharmaceuticals |
| 02/02/1994 | EP0580795A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof |
| 02/02/1994 | EP0580685A1 Pharmaceutical packaging unit containing plasminogen activators for multiple-bolus administration. |
| 02/01/1994 | CA1326672C Dihydropyridines |
| 01/31/1994 | CA2101614A1 Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| 01/27/1994 | DE4224670A1 Verwendung von â,w-Dicarbonsäuren als Fibrinogensenker Use of beta, w-dicarboxylic acids as Fibrinogensenker |
| 01/26/1994 | EP0580502A1 3-(Hydroxybenzylidenyl)-indoline-2-ones and pharmaceutical compositions containing them |
| 01/26/1994 | EP0580008A2 Phenylimidazolidine Derivatives, their preparation and use |
| 01/26/1994 | EP0579643A1 Atp analogues |
| 01/26/1994 | EP0579618A1 Pyridine- and imidazole-derived agents for cardiovascular diseases |